Drug Shortage Report for SANDOMIGRAN DS
| Report ID | 205711 |
| Drug Identification Number | 00511552 |
| Brand name | SANDOMIGRAN DS |
| Common or Proper name | SANDOMIGRAN DS 1mg Tabs |
| Company Name | PALADIN PHARMA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | PIZOTIFEN |
| Strength(s) | 1MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 Tabs |
| ATC code | N02CX |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2023-10-02 |
| Estimated end date | 2025-01-15 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-11-28 |
| Company comments | Production delays |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 MONTREAL, QUEBEC CANADA H4M 2P2 |
| Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v21 | 2024-10-30 | English | Compare |
| v22 | 2024-10-30 | French | Compare |
| v23 | 2024-11-28 | English | Compare |
| v24 | 2024-11-28 | French | Compare |